Pharmaceutical Technology Europe-10-01-2011

Pharmaceutical Technology Europe

Overcoming The Distance

October 01, 2011

Special Feature

23

10

With the Western world recovering slowly from a recession, and tighter restrictions for medical products being applied by the FDA and other regulatory authorities, more medical device R&D is being located in Asia.

Novel Excipients: A Rare Species

October 01, 2011

Interview

23

10

Where are the new excipients, the new solubilisers and sustained release excipients?

Why Good Records Management Is Key

October 01, 2011

Special Feature

23

10

The past year has seen significant consolidation of mid-size CROs, with many of them being bought or put up for sale. In particular, the top six or seven CROs seem to be signing more preferred partner deals, such as Pfizer teaming with Parexel and ICON, and Takeda?s deals with Covance and Quintiles, which is driving mid-size CROs growth through major acquisitions.

Time Is Of The Essence

October 01, 2011

Agent-In-Place

23

10

Giving contamination time to build up can cause headaches for more than just your company.

EU Market Challenges

October 01, 2011

Special Feature

23

10

Although the European market is approximately 50% smaller than the US in terms of landmass, the population of Europe is approximately 50% larger and this presents a huge market opportunity.

Taking It For Granted

October 01, 2011

23

10

As editor of Pharmaceutical Technology Europe, I often have the opportunity to visit the sites of a wide variety of companies within the industry. Though differing vastly in the technologies and staff they employ, they all share one thing in common for me: the "you learn something new every day!" factor.

News

October 01, 2011

News

23

10

Pharmacovigilance: have your say